Bringing the fundamentals into focus…
Back to Immuneering Corporation
How Immuneering Corporation stacks up
IMRX · against 285 other Healthcare companies of similar size
Profitability
20/ 100
Below the middle of the pack.
Ranked #205 of 286 · scores higher than 28% of peers
Bars: peers in each 10-point band of the profitability score37 peers with a profitability score of 20–29, including IMRX · Click a bar to see the companies
Why profitability scores 20?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 85% of peers. Return on assets: -28.3% vs peer median 1.7%
- a lower return on invested capital: weaker than 84% of peers. Return on invested capital: -33.6% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = IMRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IMRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 246 reported | -33.6% | -1.6% | 24% | 33% | |
| Operating marginHigher is better · 266 reported | Not reported | 1.6% | — | — | 33% |
| Return on assetsHigher is better · 287 reported | -28.3% | -1.0% | 22% | 33% | |
| Return on equityHigher is better · 267 reported | -52.1% | -1.8% | 17% | Context only | |
| Gross marginHigher is better · 301 reported | 0.0% | 38.5% | 6% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around IMRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 433M USD | 99 | 81 | |
| 2 | 261M USD | 98 | 97 | |
| 3 | 1.4B HKD (≈$181M) | 97 | 61 | |
| 3 | 356M AUD (≈$235M) | 97 | 81 | |
| 5 | 592M ILS (≈$160M) | 96 | 84 | |
| 201 | 365M USD | 21 | 41 | |
| 201 | 375M USD | 21 | 46 | |
| 201 | 285M USD | 21 | 38 | |
| 205 | 222M USD | 20 | 31 | |
| 205 | 238M USD | 20 | 41 | |
| 205 | 299M USD | 20 | 38 | |
| 208 | 5.7B TWD (≈$177M) | 19 | 65 | |
| 208 | 441M USD | 19 | 34 | |
| 210 | 165M USD | 18 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score